Nanosphere Inc. announced today that it has been awarded a patent for its biobarcode technology. Biobarcode is a protein detection technology that is both more sensitive and less expensive than the mass spectrometry used today. It promises much earlier detection of diseases including cancer and Alzheimer' s. The technology was developed at Northwestern University and is esclusively licensed to Nanosphere. more @ nanotechwire.com